Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics.

MLA

Roffeei, Siti Norsyuhada, et al. “Association of FTO, LEPR and MTHFR Gene Polymorphisms with Metabolic Syndrome in Schizophrenia Patients Receiving Antipsychotics.” Pharmacogenomics, vol. 15, no. 4, Mar. 2014, pp. 477–85. EBSCOhost, https://doi.org/10.2217/pgs.13.220.

APA

Roffeei, S. N., Mohamed, Z., Reynolds, G. P., Said, M. A., Hatim, A., Mohamed, E. H. M., Aida, S. A., & Zainal, N. Z. (2014). Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics. Pharmacogenomics, 15(4), 477–485. https://doi.org/10.2217/pgs.13.220

Chicago

Roffeei, Siti Norsyuhada, Zahurin Mohamed, Gavin P Reynolds, Mas Ayu Said, Ahmad Hatim, Elsa Haniffah Mejia Mohamed, Syarinaz Ahmad Aida, and Nor Zuraida Zainal. 2014. “Association of FTO, LEPR and MTHFR Gene Polymorphisms with Metabolic Syndrome in Schizophrenia Patients Receiving Antipsychotics.” Pharmacogenomics 15 (4): 477–85. doi:10.2217/pgs.13.220.